We developed a luminescence immunoassay (LIA) for follitropin, based on the synthesis of a follitropin-N-(4-aminobutyl)-N-ethylisoluminol conjugate. The luminescence tracer was purified by gel chromatography. Antibody-bound and non-bound tracer fractions were separated by using a second antibody reagent bound to magnetic particles. The assay can be performed within 24 hours and is sufficiently sensitive for the measurement of all clinically relevant follitropin concentrations including the subnormal r nge.
Introduction
In view of the well-known disadvantages of radioactive labels, non-isotopic immunoassays have been widely investigated in recent years (2 -6) . This paper describes the development and validation of a luminescence immunoassay (LIA) for human follitropin (follicle stimulating hormone, FSH), based on the synthesis pf an FSH-N-(4-aminobutyl)-N-ethylisoluminol conjugate and a solid phase (magnetic particle) double antibody Separation technique. Catalase from bovine liver, Sigma, M nchen, C 3155. ΜΑΙΑ Reagent (Anti-rabbit IgG covalently bound to paramagnetic particles), Serono, Freiburg.
Berthold luminometer (CliniLumat LB 9502).
Methods
Tracer was prepared by a modiflcation of the method of Barnard et al. (2, 3) .
The reactions were carried out s follows:
Reaction a: 10 μτηοΐ N-(4-aminobutyl)-N-ethylisoluminol (ABEI; 2.76 mg) were dissolved in 160 μg dry dimethylformamide in a water bath at 40 -50 °C for a few minutes, and 10 μιηοΐ (l mg) succinic anhydride were dissolved in 2 ml dry pyridine. Both Solutions were gassed with dry nitrogen and mixed. The reaction tube was firmly plugged and left in the dark at room temperature for 24-72 nours.
Reaction b:
Freshly prepared ABEI-hemisuccinamide (ABEI-H) was flrst made free of pyridine and dimethylformamide by distillation under low pressure in a vacuum distillation apparatus in the dark. The residue was dissolved in 25 μΐ dry dimethylformamide and incubated with 10 μηιοί (11.5 mg) N-hydroxysiiccinimidc and 30 μηιοί Ν,Ν'-dicyclohexylcarbodiimidc (6.18 mg) in 40 μΐ ciry dimcthylformamide (total incubalion volume approximalcly 65 μΐ) for 24 hours in thc dark.
Reaction c: 100 μg highly purificd follitropin was dissolved in 1000 μΐ phosphatc buffer (Na 2 HPO 4 0.05 mol/1, pH 8.0), and 200 μΐ of this solution vvere incubated vvith 10 μΐ of the reaction product * % b" (ABEl-hemisuccinamide active ester) at 4 °C for 24 hours in the dark.
The follitropin isoluminol conjugate was separated from the resulting mixture of reaction u c" by filtration on a column of Sephadex G-50 fine (length 25 cm, diameter l cm) using for elution 0.05 mol/1 Tris-HCl buffer (pH 7.5) containing 0.02 mol/1 sodium azide. The eluate was collected in thirty l ml fractions. Luminescence reactivity was measured in each fraction after dilution vvith Soerenserfs phosphate buffer containing l0 g/l bovine serum albumin using a Berthold luminometer.
The luminescence immunoassay was performed according to the scheine in table l. For use in the assay, the ΜΑΙΑ reagent was washed once in assay buffer, decanted and resuspended in the twofold buffer volume. After the second incubation, the tubes were decanted using a magnetic rack, washed three times with Soerensen's phosphate buffer (10 g/l bovine serum albuniin) and catalase solution was added. Thereafter luminescence was measured in a Berthold luminometer, which automatically started the luminescence reaction by injecting urea hydrogen peroxide solution in the dark. 
Results
Figure l shows that two peaks of luminescence were found in the eluates of the Sephadex G 50 fine column. When follitropin was measured in each eluate fraction by an immunoradiometric assay (Nichols Institute), peak 2 was found to be devoid of follitropin reactivity. The highest follitropin immunoreactivity was found in tubes 7-9 which were mixed for use s the luminescence tracer. The follitropin concentration of the combined fraction was approximately 1500
Precision profile
Intraassay coefficients of Variation were 4.8%, 3.1% and 6.7% in the ranges of 10, 30 and 90 IU/1 (n = 20) respectively. Interassay coefficients of Variation were found to be 5.9%, 5.8% and 9.4% in the same ranges (n = 20). The specificity of the antiserum used is demonstrated by the cross reactions at 50% inhibition (1): follitropin 100%, thyrotropin 1.9%, lutropin 0.2%, human cho*· rionic gonadotropin: unmeasunibly low.
Accuracy
Increasing amounts of Standard were added to the same serum sample and aliquots were assayed (recovery test). Figure 3 demonstrates the straight regression line obtained for the added amount versus measured amount, demonstrating the equivalence of follitropin in Standard and serum and the absence of matrix influences (see also tab. 2). Figure 4 shows the results of the parallelism test. Increasing dilutions of a serum sample with high follitropin concentration (menopausal serum) were assayed. The straight linear regression for the dilution factor versus the measured amounts of follitropin proved that the assay is independent of concentrations and interferences which may be present in the sample (see also tab. 3). 
Discussion
The use of radioactive tracers in immunoassays has certain drawbacks such s human contact with radioactive material and the short shelf life of the labelled antigens. The luminescence immunoassay (LIA) has solved these probleras (4).
Follitropin determinations are being increasingly requested for the evaluation of patients with delayed puberty, amenorrhoea, pituitary tumours and infertility. We therefore developed -to the best of our knowledge for the first time -a follitropin LIA for clinical use. Labelling of highly purified follitropin with ABEI was performed in 3 subsequent Steps in a modification of the method of Barnard et al. (2, 3) . No attempt was made to purify the intermediate reaction products, because of the imstable ilature of ABEI-hemisuccinamide active ester (7), and because final tracer purification was necessary anyway. The resulting stable follitropin-ABEI-hemisuccinamide conjugate was easily purified by gel chromatography. Many experiments were performed to find the optimal ratios for the final reaction of ABEI-hemisuccinamide active ester with follitropin. Although the concentrations indicated above may not be optimal, they led to the highest quantity of the final reaction product. The conjugate has an excellent yield of luminescence impulses, very little non-specific binding and is stable for at least 9 months. Separation of antibody-bound and non-bound tracer fractions was readily performed with a commercially available paramagnetic particle "second antibody" reagent. It proved to be essential to dilute this reagent in buffer cpntaining only 10 g/l;Albumin, äs higher concentrations of albumin led to a quenching of luminescence activity. The assay can be performed at room temperature within 24 hours. It is well reproducible, has a sensitivity which allows the measurement of all clinically relevant values including subnormal ones, shows good correlation with a widely used commercial IRMA from a reference laboratory, and may therefore be recommended for clinical use.
